Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$0.28 - $1.16 $1,046 - $4,333
3,736 Added 292.56%
5,013 $1,000
Q1 2024

May 02, 2024

SELL
$1.06 - $1.67 $2,571 - $4,051
-2,426 Reduced 65.51%
1,277 $1,000
Q4 2023

Jun 14, 2024

BUY
$1.26 - $1.79 $2,633 - $3,741
2,090 Added 129.57%
3,703 $6,000
Q4 2023

Jan 19, 2024

BUY
$1.26 - $1.79 $2,633 - $3,741
2,090 Added 129.57%
3,703 $6,000
Q1 2023

Jun 14, 2024

BUY
$1.2 - $2.19 $403 - $735
336 Added 26.31%
1,613 $2,000
Q1 2023

Apr 05, 2023

BUY
$1.2 - $2.19 $276 - $503
230 Added 16.63%
1,613 $2,000
Q4 2022

Jan 19, 2023

BUY
$1.63 - $3.52 $2,254 - $4,868
1,383 New
1,383 $0

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.